Abstracts tagged "epidemiologic methods and rheumatic disease"

Abstract Number: 1153 • 2018 ACR/ARHP Annual Meeting
EULAR ‘Points to Consider’ for the Conduction of Workforce Requirement Studies in Rheumatology
Christian Dejaco^1,2, Polina Putrik³, Julia Unger⁴, Daniel Aletaha⁵, Gerolamo Bianchi⁶, Johannes W. J. Bijlsma⁷, Annelies Boonen⁸, Nada Cikes⁹, Axel Finckh¹⁰, Laure Gossec¹¹, Tore Kvien¹², Joao Madruga Dias¹³, Eric L. Matteson¹⁴, Francisca Sivera¹⁵, Tanja Stamm¹⁶, Zoltan Szekanecz¹⁷, Dieter Wiek¹⁸, Angela Zink¹⁹, Sofia Ramiro²⁰ and Frank Buttgereit²¹, ¹Rheumatology, Hospital of Bruneck, Bruneck, Italy, ²Rheumatology and Immunology, Medical University Graz, Graz, Austria, ³Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ⁴FH JOANNEUM, University of Applied Sciences, Bad Gleichenberg, Austria, ⁵Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Vienna, Austria, ⁶Rheumatology, ASL3-Azienda Sanitaria Genovese, Genua, Italy, ⁷Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ⁸Caphri Research Institute, Maastricht, Netherlands, ⁹University of Zagreb School of Medicine, Zagreb, Croatia, ¹⁰University Hospital of Geneva, Geneva, Switzerland, ¹¹Rheumatology, Sorbonne Université, Paris, France, ¹²Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ¹³Centro Hospitalar Médio Tejo, Torres Novas, Portugal, ¹⁴Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ¹⁵Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, ¹⁶Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Vienna, Austria, ¹⁷Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, Debrecen, Hungary, ¹⁸EULAR Standing Committee of PARE, Zurich, Switzerland, ¹⁹Epidemiology Unit / Rheumatology and Clinical Immunology, German Rheumatism Research Centre (DRFZ) / Charité University Hospital, Berlin, Germany, ²⁰Zuyderland Medical Center, Heerlen & Leiden University Medical Center, Leiden, Netherlands, ²¹Department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany
Background/Purpose: Recommendations and strategies have been developed for early referral, diagnosis and treatment of rheumatic diseases. These strategies, however, can only be implemented if sufficient…
Abstract Number: 2265 • 2015 ACR/ARHP Annual Meeting
Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey
Jaime C Branco¹, Ana M. Rodrigues², Nelia Gouveia³, Leonor P Costa⁴, Monica Eusebio⁵, Sofia Ramiro^2,4,6, Pedro Machado^4,7,8, Filipa Mourão^4,9,10, Inês Silva^9,11, Pedro Laires⁴, Alexandre Sepriano^4,12, Filipe Araújo^4,13, Sónia Gonçalves⁴, Pedro S Coelho^4,14, Viviana Tavares⁴, Jorge Cerol^4,15, Jorge M Mendes^4,14, Loreto Carmona¹⁶ and Helena Canhao¹⁷, ¹NOVA Medical School/faculdade de ciências médicas, Universidade Nova de Lisboa, Lisboa, Portugal, ²CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade de Ciências Médicas da UNL, Lisbon, Portugal, ³CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade Ciências Médicas da UNL, Lisbon, Portugal, ⁴EpiReumaPt Study Group, Lisbon, Portugal, ⁵Portuguese Society of Rheumatology, Lisbon, Portugal, ⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁷Clínica Universitária de Reumatologia, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, ⁸University College London - MRC Centre for Neuromuscular Diseases,, London, United Kingdom, ⁹Centro Hospitalar Lisboa Ocidental (CHLO- E.P.E.), Lisbon, Portugal, ¹⁰NOVA Medical School - Faculdade Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal, ¹¹EpiReumaPt Study Group, lisbon, Portugal, ¹²Rheumatology, Hospital de Egas Moniz - CHLO, Lisbon, Portugal, Lisbon, Portugal, ¹³Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, ¹⁴NOVA Information Management School, Lisbon, Portugal, ¹⁵Portuguese Catholic University, Lisbon, Portugal, ¹⁶Instituto de Salud Musculoesquelética, Madrid, Spain, ¹⁷Hospital Santa Maria - Serviço de Reumatologia, Lisboa, Portugal
Background/Purpose: Rheumatic and musculoskeletal diseases (MSKD) are a prevalent leading cause of disability and consume a large amount of healthcare and social resources. MSKD have been…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].